A single injection of MAM01 may offer months-long protection against malaria - a potential game changer for children and pregnant women in high-risk regions.
FDA authorizes Phase 1–3 clinical trials of gene-edited pig kidneys (EGEN-2784) for patients with end-stage renal disease, offering a potential new option beyond dialysis.
From AI-powered recruitment to remote data capture, digital platforms are redefining clinical research with faster enrollment, better data, and improved patient outcomes.